Prothena Corp Public (PRTA) Operating Expenses (2012 - 2026)
Prothena Corp Public (PRTA) recorded quarterly Operating Expenses of $21.0 million in Q1 2026, down 13.11% quarter-over-quarter from $24.2 million in Q4 2025, and down 69.23% on a YoY basis from $68.4 million in Q1 2025.
Prothena Corp Public (PRTA) Operating Expenses (2012 - 2026) Analysis & Trends
Prothena Corp Public's Operating Expenses history runs 15 years deep, the most recent figure standing at $21.0 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 69.23% year-over-year to $21.0 million; the TTM figure through Mar 2026 stood at $177.0 million (down 36.01% YoY), while the FY2025 annual figure was $224.3 million, down 22.57% from the prior year.
- Operating Expenses was $21.0 million for Q1 2026 at Prothena Corp Public, down from $24.2 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $89.0 million in Q2 2025 to a low of $21.0 million in Q1 2026.
- Historically, Operating Expenses has averaged $59.0 million across 5 years, with a median of $67.0 million in 2024.
- The sharpest annual moves came in 2022 and 2026: Operating Expenses soared 73.14% in 2022, then sank 69.23% in 2026.
- A 5-year view of Operating Expenses shows it stood at $50.0 million in 2022, then surged by 57.68% to $78.8 million in 2023, then dropped by 14.98% to $67.0 million in 2024, then slumped by 63.86% to $24.2 million in 2025, then dropped by 13.11% to $21.0 million in 2026.
- The last three Operating Expenses figures came in at $21.0 million (Q1 2026), $24.2 million (Q4 2025), and $42.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - | 21.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.05 Mn |
| Dec 31, 2025 | 24.22 Mn |
| Sep 30, 2025 | 42.66 Mn |
| Jun 30, 2025 | 89.04 Mn |
| Mar 31, 2025 | 68.41 Mn |
| Dec 31, 2024 | 67.02 Mn |
| Sep 30, 2024 | 67.48 Mn |
| Jun 30, 2024 | 73.64 Mn |
| Mar 31, 2024 | 81.58 Mn |
| Dec 31, 2023 | 78.83 Mn |
| Sep 30, 2023 | 74.56 Mn |
| Jun 30, 2023 | 70.52 Mn |
| Mar 31, 2023 | 58.49 Mn |
| Dec 31, 2022 | 50.00 Mn |
| Sep 30, 2022 | 51.85 Mn |
| Jun 30, 2022 | 44.52 Mn |
| Mar 31, 2022 | 39.10 Mn |
| Dec 31, 2021 | 34.26 Mn |
| Sep 30, 2021 | 29.95 Mn |
| Jun 30, 2021 | 32.12 Mn |